biosimilars update: rheumatology and arthritis treatment
Published 1 year ago • 404 plays • Length 8:19Download video MP4
Download video MP3
Similar videos
-
4:33
biosimilars
-
4:42
biosimilars vs. biologics: side effects, safety and effectiveness
-
1:10:48
tnr grand rounds - update on biosimilars
-
38:15
biosimilars and biologics
-
2:47
biologics vs. biosimilars: what’s the difference?
-
11:24
adalimumab biosimilar bi 695501 (cyltezo®; adalimumab-adbm) in rheumatoid arthritis
-
0:29
join the rheumatology patient advisory council
-
56:06
biosimilars virtual lunch and learn
-
4:13
clinical updates in rheumatoid arthritis
-
34:22
pinpointing the top questions and considerations about biosimilars in rheumatology
-
3:31
treatment persistence and switching patterns of an adalimumab biosimilar
-
1:09:11
biosimilars: what you need to know
-
2:08
biologics and biosimilars basics: what are biosimilars?
-
3:45
what are biosimilars? how do they work for arthritis?
-
0:31
should i take medication or not? how to decide?
-
4:21
biosimilars and rheumatoid arthritis | making the switch
-
3:42
rheumatic diseases: biosimilars vs original biologics
-
16:32
the rheumatology perspective - ihe biosimilars forum
-
3:35
tnf inhibitors: an overview